UTAH MEDICAL PRODUCTS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $2.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $2.48M.
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $2.35M, a 10.46% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $2.62M, a 3.97% increase from fiscal 2021.
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2021 was $2.52M, a 31.59% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|---|
| 2025-12-31 | $2.48M 10-K · filed 2026-03-27 | |
| 2024-12-31 | $2.79M 10-K · filed 2026-03-27 | |
| 2023-12-31 | $2.35M 10-K · filed 2025-03-26 | $2.35M 10-K · filed 2026-03-27 |
| 2022-12-31 | $2.62M 10-K · filed 2025-03-26 | |
| 2021-12-31 | $2.52M 10-K · filed 2024-03-26 | |
| 2020-12-31 | $1.92M 10-K/A · filed 2023-03-28 | |
| 2019-12-31 | $2.51M 10-K · filed 2022-03-25 | |
| 2018-12-31 | $2.13M 10-K · filed 2021-03-26 | |
| 2017-12-31 | $3.09M 10-K · filed 2020-03-16 | |
| 2016-12-31 | $3.00M 10-K · filed 2019-03-14 | |
| 2015-12-31 | $2.70M 10-K · filed 2018-03-06 | |
| 2014-12-31 | $2.63M 10-K · filed 2017-03-08 | |
| 2013-12-31 | $2.58M 10-K · filed 2016-03-10 | |
| 2012-12-31 | $2.74M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $2.65M 10-K · filed 2014-03-12 | |
| 2010-12-31 | $2.91M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |